CMS Energy Corporation (CMS)-エネルギー分野:企業M&A・提携分析

◆英語タイトル:CMS Energy Corporation (CMS) - Power - Deals and Alliances Profile
◆商品コード:DATA8013012
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:発電・エネルギー
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CMS Energy Corporation (CMS Energy) is an energy utility which provides electricity, natural gas, and banking services. It generates, procures, transmits, distributes, and sells energy. The company produces power from coal, oil and gas, hydro, wind, and solar sources. CMS Energy purchases, transmits, stores, distributes, and sells natural gas. It procures natural gas from Canadian producers and gas customer choice (GCC) suppliers. Through its subsidiaries and equity investments, CMS Energy owns interest in power generation facilities, and purchases and sells energy commodities. The company serves individuals and businesses in the alternative energy, chemical, automotive, metal, food products, and other industries in Michigan. CMS Energy is headquartered in Jackson, Michigan, the US.

CMS Energy Corporation (CMS) – Power – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Power eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CMS Energy Corporation, Power, Deals By Year, 2011 to YTD 2017 6
CMS Energy Corporation, Power Deals By Type, 2011 to YTD 2017 7
CMS Energy Corporation, Power, Deals By Region, 2011 to YTD 2017 8
CMS Energy Corporation, Power, Deals By Sector, 2011 to YTD 2017 9
CMS Energy Corporation, Power, Deals Summary, 2011 to YTD 2017 10
CMS Energy Corporation, Power, Deal Details 11
Asset Purchase 11
CMS Enterprises to Acquire Delta Solar Power Project in Michigan, US from groSolar 11
Consumers Energy Plans to Acquire Natural Gas-Fired Plant in Michigan, US 12
Partnerships 13
SunPower Forms Partnership with Consumers Energy 13
Equity Offering 14
CMS Energy Plans to Raise up to USD100 Million in Public Offering of Shares 14
Debt Offering 15
Consumers Energy Raises USD350 Million in Public Offering of 3.95% Bonds Due 2047 15
CMS Energy Raises USD350 Million in Public Offering of 3.45% Notes Due 2027 17
Consumers Energy Raises USD450 Million in Public Offering of 3.25% Bonds Due 2046 18
CMS Energy Raises USD250 Million in Public Offering of 3.6% Notes Due 2025 20
Consumers Energy Raises USD250 Million in Public Offering of 4.1% Bonds Due 2045 21
Consumers Energy Raises USD250 Million in Public Offering of 4.35% Bonds Due 2064 22
Consumers Energy Raises USD250 Million in Public Offering of 3.125% Bonds Due 2024 23
CMS Energy Completes Public Offering Of 4.875% Notes Due 2044 For US$300 Million 24
CMS Energy Completes Public Offering Of 3.875% Notes Due 2024 For US$250 Million 26
Consumers Energy Completes Public Offering Of 3.95% Bonds Due 2043 For US$425 Million 28
CMS Energy Completes Public Offering Of 4.7% Senior Notes Due 2042 For US$250 Million 30
Consumers Energy Completes Public Offering Of 2.85% First Mortgage Bonds Due 2022 For US$375 Million 31
CMS Energy Completes Public Offering Of 5.05% Senior Notes Due 2022 For US$300 Million 32
CMS Energy Completes 2.75% Senior Notes Offering For US$250 Million 34
Asset Transactions 35
ReEnergy Acquires 100% Equity Stake In Exeter Tire-to-Energy Facility From CMS Enterprises 35
CMS Energy Corporation – Key Competitors 36
CMS Energy Corporation – Key Employees 37
CMS Energy Corporation – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Joint Venture 40
Recent Developments 41
Oct 26, 2017: CMS Energy Announces Third Quarter Earnings Of $0.61 Per Share, Or $0.62 Per Share On An Adjusted Basis; Raises 2017 Adjusted Earnings Guidance, And Introduces 2018 Adjusted Earnings Guidance 41
Aug 01, 2017: groSolar, CMS Energy start operations of 3.4MW solar project in Wisconsin 42
Jul 28, 2017: CMS Energy Announces Second Quarter Earnings Of $0.33 Per Share; Reaffirms 2017 Adjusted Earnings Guidance 43
Jun 29, 2017: CMS Energy and Consumers Energy Name JF Brossoit as Senior Vice President of Transformation, Operations Support and Engineering; Dan Malone to Retire Nov. 1 44
May 22, 2017: CMS Energy and Consumers Energy Names Brandon Hofmeister, David Mengebier, and Lauren Youngdahl Snyder to New Leadership Positions effective July 1 45
May 15, 2017: Consumers Energy Proposes Program to Help Large Michigan Businesses Use 100 Percent Renewable Energy 46
May 01, 2017: CMS Energy and Consumers Energy Executive Vice President and Chief Financial Officer Tom Webb Named Vice Chairman; Rejj 47
May 01, 2017: CMS Energy Announces First Quarter Earnings Of $0.71 Per Share; Reaffirms 2017 Earnings Guidance 48
Feb 23, 2017: CMS Energy Announces Leadership Changes Focused on World-Class Performance, Workforce 49
Feb 02, 2017: CMS Energy reports lower Q4 net income, raises guidance for 2017 50
Dec 08, 2016: Palisades Power Purchase Agreement to End Early 51
Nov 17, 2016: CMS Energy Names Jean-Francois Brossoit as Vice President of Transformation and Shared Services 52
Aug 09, 2016: CMS Energy Strengthens Senior Leadership Team 53
Apr 28, 2016: CMS Energy Announces First Quarter Earnings Of $0.59 Per Share, Reaffirms 2016 Earnings Guidance Of $1.99 To $2.02 Per Share 54
Jan 21, 2016: CMS Energy Announces New Chief Compliance Officer 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
CMS Energy Corporation, Power, Key Facts, 2016 2
CMS Energy Corporation, Power, Deals Summary, 2011 to YTD 2017 2
CMS Energy Corporation, Power, Deals By Year, 2011 to YTD 2017 6
CMS Energy Corporation, Power Deals By Type, 2011 to YTD 2017 7
CMS Energy Corporation, Power, Deals By Region, 2011 to YTD 2017 8
CMS Energy Corporation, Deals By Sector, 2011 to YTD 2017 9
CMS Energy Corporation, Power, Deals Summary, 2011 to YTD 2017 10
CMS Enterprises to Acquire Delta Solar Power Project in Michigan, US from groSolar 11
Consumers Energy Plans to Acquire Natural Gas-Fired Plant in Michigan, US 12
SunPower Forms Partnership with Consumers Energy 13
CMS Energy Plans to Raise up to USD100 Million in Public Offering of Shares 14
Consumers Energy Raises USD350 Million in Public Offering of 3.95% Bonds Due 2047 15
CMS Energy Raises USD350 Million in Public Offering of 3.45% Notes Due 2027 17
Consumers Energy Raises USD450 Million in Public Offering of 3.25% Bonds Due 2046 18
CMS Energy Raises USD250 Million in Public Offering of 3.6% Notes Due 2025 20
Consumers Energy Raises USD250 Million in Public Offering of 4.1% Bonds Due 2045 21
Consumers Energy Raises USD250 Million in Public Offering of 4.35% Bonds Due 2064 22
Consumers Energy Raises USD250 Million in Public Offering of 3.125% Bonds Due 2024 23
CMS Energy Completes Public Offering Of 4.875% Notes Due 2044 For US$300 Million 24
CMS Energy Completes Public Offering Of 3.875% Notes Due 2024 For US$250 Million 26
Consumers Energy Completes Public Offering Of 3.95% Bonds Due 2043 For US$425 Million 28
CMS Energy Completes Public Offering Of 4.7% Senior Notes Due 2042 For US$250 Million 30
Consumers Energy Completes Public Offering Of 2.85% First Mortgage Bonds Due 2022 For US$375 Million 31
CMS Energy Completes Public Offering Of 5.05% Senior Notes Due 2022 For US$300 Million 32
CMS Energy Completes 2.75% Senior Notes Offering For US$250 Million 34
ReEnergy Acquires 100% Equity Stake In Exeter Tire-to-Energy Facility From CMS Enterprises 35
CMS Energy Corporation, Key Competitors 36
CMS Energy Corporation, Key Employees 37
CMS Energy Corporation, Subsidiaries 39
CMS Energy Corporation, Joint Venture 40

★海外企業調査レポート[CMS Energy Corporation (CMS)-エネルギー分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Prothena Corp Plc (PRTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Prothena Corp Plc (Prothena) is a clinical biotechnology company, which discovers, develops and markets novel medicines that are indicated for the treatment of diseases associated with neuroscience and orphan diseases. The company develops monoclonal antibodies directed specifically at disea …
  • Laureate Education, Inc.:企業のM&A・事業提携・投資動向
    Laureate Education, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laureate Education, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Benvenue Medical, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Benvenue Medical, Inc (Benvenue Medical) is a manufacturer, designer and distributor of minimally invasive systems and other medical devices. The product portfolio of the company includes Luna, a 3D interbody fusion system designed for the treatment to restore disc height. Blazer, is a verte …
  • Baron Oil Plc (BOIL):企業の財務・戦略的SWOT分析
    Summary Baron Oil Plc (Baron Oil), formerly Gold Oil PLC is an oil and gas exploration and production company. The company identifies and develops crude oil and natural gas interests in Latin America including Peru and Colombia. It holds working interests of Nancy Burdine Maxine oil field, oil and g …
  • Avalign Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avalign Technologies Inc (Avalign), a subsidiary of Arlington Capital Partners, is a medical device company that supplies surgical implants, instruments, and delivery systems. The company offers precision machined instruments, cutting instruments, delivery systems, cases and trays, german sp …
  • Jiangxi Copper Company Limited:戦略・SWOT・企業財務分析
    Jiangxi Copper Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jiangxi Copper Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Abaxis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abaxis Inc (Abaxis) is a provider of technology, tools and services for wide range of medical applications for human and veterinary patient-care. The company focuses on development, manufacture, and marketing of portable blood analysis systems. Its portfolio encompasses patented products inc …
  • Selexys Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Selexys Pharmaceuticals Corp (Selexys Pharmaceuticals) is a biopharmaceutical company that develops drugs for the treatment of inflammatory and thrombotic diseases. The company’s products comprise Anti-P-selectin, which blocks selectin function and prevents white blood cells from initiating …
  • Bioanalytical Systems Inc (BASI):企業の財務・戦略的SWOT分析
    Summary Bioanalytical Systems Inc (Bioanalytical Systems) is a contract research organization that provides drug discovery and development services, and analytical instruments. The company’s contract research services include screening and pharmacological testing, formulation development, preclinica …
  • Prologis Inc (PLD):企業の財務・戦略的SWOT分析
    Prologis Inc (PLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Merus Labs International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Merus Labs International Inc (Merus Labs International), formerly Merus Labs Inc, a subsidiary of Norgine BV, is a pharmaceutical company that provides medicinal products. The company offers products in the therapeutic areas of cardiovascular, oncology support, women's health, urology, and i …
  • ICU Medical Inc (ICUI)-医療機器分野:企業M&A・提携分析
    Summary ICU Medical Inc (ICU Medical) is a medical device company which develops, manufactures, distributes and sells devices used for infusion therapy, cancer diagnosis and treatment and critical care applications. The company’s major products include needle free vascular access devices, closed sys …
  • Grupo Biotoscana SL (GBIO33):製薬・医療:M&Aディール及び事業提携情報
    Summary Grupo Biotoscana SL (Biotoscana) is a biopharmaceutical company that develops, manufactures and markets advanced medicines for unmet medical needs. The company offers products such as vidaza, ladevina, zyvalix, mielozitidina, votrynib, bozob, timab, enzastar, capebina, leprid, olvestran, toc …
  • Turkiye Petrolleri Anonim Ortakligi:石油・ガス:M&Aディール及び事業提携情報
    Summary Turkiye Petrolleri Anonim Ortakligi (TPAO) is an oil and gas company that carries out exploration, refining, and marketing services for oil and gas. The company offers services such as geological services, seismic services, drilling and domestic and international oil and natural gas producti …
  • Tetraphase Pharmaceuticals Inc (TTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Tetraphase Pharmaceuticals Inc (Tetraphase) is a pharmaceutical company that discovers and develops antibiotic resistance medicines. The company’s products under clinical development include eravacycline, TP-271, and TP-6076. It develops products for the treatment of respiratory diseases cau …
  • Radius Health Inc (RDUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Radius Health Inc (Radius Health), formerly NuVios, Inc., is a biopharmaceutical company that develops and commercializes therapeutics for osteoporosis, oncology and endocrine diseases. The company’s product includes abaloparatide injection, which is used for the treatment of postmenopausal …
  • Ceres Power Holdings Plc (CWR):電力:M&Aディール及び事業提携情報
    Summary Ceres Power Holdings Plc (Ceres Power) is an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power and heat …
  • Midatech Pharma US Inc:医療機器:M&Aディール及び事業提携情報
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. It is a subsidiary of Midatech Pharma Plc. The company’s product portfolio includes …
  • Marmen Inc:企業の戦略的SWOT分析
    Marmen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Serina Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Serina Therapeutics Inc (Serina Therapeutics) is a drug company that develops therapeutics for cancer, inflammation, pain, and metabolic disorders. The company’s pipeline product includes SER-214, SER-226, SER-228, SER-232, and other proprietary drugs. It uses proprietary technology, polyoxa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆